Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Berrino F, Sant M, Verdecchia A, Capocaccia R, Hakulinen T and Estève J (1995) Survival of cancer patients in Europe. The EUROCARE Study. IARC Scientific Publication No 132, Lyon: International Agency for Research on Cancer
Berrino F, Capocaccia R, Estève J, Gatta G, Hakulinen T, Micheli A, Sant M and Verdecchia A (1999) Survival of cancer patients in Europe: the EUROCARE Study II. IARC Scientific Publication No 151. Lyon: International Agency for Research on Cancer
Berrino F, Gatta G, Sant M and Capocaccia R (2001) The EUROCARE study of survival of cancer patients in Europe: aims, current status, strengths and weaknesses. Eur J Cancer 37: 673–677
Coebergh JWW, Sant M, Berrino F and Verdecchia A (1998) Survival of adult cancer patients in Europe diagnosed from 1978–1989: the Eurocare II Study. Eur J Cancer 34: 14
Capocaccia R, Gatta G, Magnani C, Stiller C and Coebergh JWW (2001) Childhood Cancer Survival in Europe 1978–1992: the Eurocare Study. Eur J Cancer 37: 6
Gatta G, Capocaccia R, Sant M, Bell CMJ, Coebergh JWW, Damhuis R, Faivre J, Martinez Garcia C, Pawlega J, Ponz de Leon M, Pottier D, Raverdy N, Williams EMI and Berrino F (2000) Understanding variations in survival for colorectal cancer in Europe: a EUROCARE High-Resolution Study. Gut 47, (4)533–538
Irwig L and Armstrong B (2000) EUROCARE-2: relevance for assessment of quality of cancer services?. Lancet 355: 427–428
Mariotto A, Capocaccia R, Verdecchia A, Micheli A, Feuer EJ, Pickle L and Klegg L (2001). Projecting SEER cancer survival rates to the US: an ecological approach, CCC, accepted for publication
Parkin DM, Muir CS, Whelan SL, Ferlay J, Raymond L and Young J (1997) (eds) Cancer Incidence in Five Continents. VII, IARC Scient Publ No 120. Lyon: International Agency for Research on Cancer
Peto R, Boreham J, Clarke M, Davies C and Beral V (2000) UK and USA breast cancer death down 25% in year 2000 at ages 20–69 years. Lancet 355: (1822)
Ponz de Leon M, Di Gregorio C, Roncucci L, Benatti P, Fante R, Rossi G, Foroni M, Pedroni M and Sassatelli R (1998). Epidemiology of tumours of colon and rectum. Incidence, mortality, familiality and survival in the health care district of Modena 1984–1995. Università di Modena,
Verdecchia A, Micheli A and Gatta G (1997) Survival of Cancer Patients in Italy. The ITACARE Study. Tumori 83: No.1
Woodman CBJ, Gibbs A, Scott N, Haboubi NY and Collins S (2001). Are differences in stage at presentation a credible explanation for reported differences in the survival of patients with colorectal cancer in Europe?
Author information
Authors and Affiliations
Additional information
In this paper (Gatta et al, 2000) the HR data for Modena were restricted to cases diagnosed in 1990–91 and from a smaller (urban) area than that considered in EUROCARE II (1985–1989) which included cases diagnosed in the whole province in 1988–89. The HR study was in fact confined to the Modena colorectal cancer registry which covers only part of the province. The incidence in 1990–91 was 315 cases, 306 of which were eligible for inclusion in the study (Ponz de Leon et al, 1998)
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Gatta, G., Capocaccia, R. & Berrino, F. Cancer survival differences between European populations: the UK uneasiness. Br J Cancer 85, 785–786 (2001). https://doi.org/10.1054/bjoc.2001.1999
Published:
Issue date:
DOI: https://doi.org/10.1054/bjoc.2001.1999
